|
BMJ: Erroneous Drug Label Points to Broad Problems With FDA Label Review Process
Two experts are calling on the FDA to require a drug facts box in prescription drug labeling, pointing to an erroneous Aricept label as a signal of wider problems with the label review process.
This article is viewable by subscribers only. To view this article, please select an option below.
|
|
Subscribe
Archives